Rohto Pharmaceutical

Rohto Pharmaceutical Co., Ltd.
Native name	ロート製薬株式会社
Romanized name	Rōto Seiyaku kabushiki gaisha
Company type	Public KK
Traded as	TYO: 4527
Industry	FMCG; Pharmaceuticals;
Founded	Higashinari-ku, Osaka, Japan (September 15, 1949, to reorganize "Shintendo, Yasutami Yamada pharmaceutical Company")
Founder	Yasutami Yamada
Headquarters	Ikuno-ku, Osaka, Japan
Key people	Kunio Yamada (chair and CEO, great-grandson of the founder); Toshiaki Yoshino (president and COO);
Revenue	¥120,292 million (FY 2011); ¥115,472 million (FY 2010);
Operating income	¥13,624 million (FY 2011); ¥13,105 million (FY 2010);
Net income	¥8,184 million (FY 2011); ¥7,966 million (FY 2010);
Total assets	¥136,008 million (FY 2011); ¥126,472 million (FY 2010);
Total equity	¥83,627 million (FY 2011); ¥77,911 million (FY 2010);
Number of employees	5,518 (March 31, 2013)
Subsidiaries	Mentholatum; Rohto Advanced Research Hong Kong Ltd
Website	www.rohto.co.jp/global/
	Footnotes / references; "Financial Results for the Fiscal Year Ended March 31, 2012" (PDF). Rohto Pharmaceutical Co., Ltd. May 11, 2012. Retrieved November 12, 2012.;

Rohto Pharmaceutical Co., Ltd. (ロート製薬株式会社, Rōto Seiyaku Kabushiki-gaisha) is a multinational fast-moving consumer goods and pharmaceutical corporation headquartered in Ikuno-ku, Osaka, Japan, with a presence in North America, Europe and Asia. The company is listed on the stock exchange, having posted steady increases in revenues from ¥95,619 million in 2006 to ¥120,292 million in 2011. Skin Care contributes to 61.3% of the revenues while Eye Care contributes to 21% of their sales.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[Financial_Results_group=*-1] "Financial Results for the Fiscal Year Ended March 31, 2012" (PDF). Rohto Pharmaceutical Co., Ltd. May 11, 2012. Retrieved November 12, 2012.